Elevance Health Forecast, price target & analysts
Elevance Health Target price 2026 - Analyst rating & recommendation
Elevance Health Classifications & Recommendation
Elevance Health Price Target
| Target Price | $465.12 |
| Price | $386.43 |
| Potential |
20.36%
register free of charge
|
| Number of Estimates | 25 |
|
25 Analysts have issued a price target Elevance Health 2027 .
The average Elevance Health target price is $465.12.
This is
20.36%
register free of charge
$516.60
33.69%
register free of charge
$396.93
2.72%
register free of charge
|
|
| A rating was issued by 29 analysts: 19 Analysts recommend Elevance Health to buy, 10 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Elevance Health stock has an average upside potential 2027 of
20.36%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 199.13 | 198.51 |
| 12.62% | 0.31% | |
| EBITDA Margin | 4.39% | 5.35% |
| 20.29% | 21.89% | |
| Net Margin | 2.84% | 3.00% |
| 15.93% | 5.51% |
24 Analysts have issued a sales forecast Elevance Health 2026 . The average Elevance Health sales estimate is
This results in the following potential growth metrics:
18 Analysts have issued an Elevance Health EBITDA forecast 2026. The average Elevance Health EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
26 Elevance Health Analysts have issued a net profit forecast 2026. The average Elevance Health net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 25.21 | 27.43 |
| 1.83% | 8.81% | |
| P/E | 14.09 | |
| EV/Sales | 0.53 |
26 Analysts have issued a Elevance Health forecast for earnings per share. The average Elevance Health EPS is
This results in the following potential growth metrics and future valuations:
Elevance Health...
Current Elevance Health Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Leerink Partners |
Locked
➜
Locked
|
Locked | Jul 17 2026 |
| Baird |
Locked
➜
Locked
|
Locked | Jul 16 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Jul 16 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Jul 16 2026 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Jul 16 2026 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Jul 16 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Jul 14 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Leerink Partners:
Locked
➜
Locked
|
Jul 17 2026 |
|
Locked
Baird:
Locked
➜
Locked
|
Jul 16 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Jul 16 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Jul 16 2026 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Jul 16 2026 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Jul 16 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Jul 14 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
